Jamie O Lo1, Matthias C Schabel2, Victoria H J Roberts3, Terry K Morgan4, Juha P Rasanen5, Christopher D Kroenke6, Sophie R Shoemaker3, Eliot R Spindel7, Antonio E Frias8. 1. Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR. Electronic address: loj@ohsu.edu. 2. Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR. 3. Division of Diabetes, Obesity, and Metabolism, Oregon National Primate Research Center, Portland, OR. 4. Department of Pathology, Oregon Health & Science University, Portland, OR. 5. Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR. 6. Advanced Imaging Research Center, Oregon Health & Science University, Portland, OR; Division of Neuroscience, Oregon National Primate Research Center, Portland, OR. 7. Division of Neuroscience, Oregon National Primate Research Center, Portland, OR. 8. Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR; Division of Diabetes, Obesity, and Metabolism, Oregon National Primate Research Center, Portland, OR; Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Portland, OR.
Abstract
OBJECTIVE: We previously demonstrated that prenatal nicotine exposure decreases neonatal pulmonary function in nonhuman primates, and maternal vitamin C supplementation attenuates these deleterious effects. However, the effect of nicotine on placental perfusion and development is not fully understood. This study utilizes noninvasive imaging techniques and histological analysis in a nonhuman primate model to test the hypothesis that prenatal nicotine exposure adversely effects placental hemodynamics and development but is ameliorated by vitamin C. STUDY DESIGN: Time-mated macaques (n = 27) were divided into 4 treatment groups: control (n = 5), nicotine only (n = 4), vitamin C only (n = 9), and nicotine plus vitamin C (n = 9). Nicotine animals received 2 mg/kg per day of nicotine bitartrate (approximately 0.7 mg/kg per day free nicotine levels in pregnant human smokers) from days 26 to 160 (term, 168 days). Vitamin C groups received ascorbic acid at 50, 100, or 250 mg/kg per day with or without nicotine. All underwent placental dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) at 135-140 days and Doppler ultrasound at 155 days to measure uterine artery and umbilical vein velocimetry and diameter to calculate uterine artery volume blood flow and placental volume blood flow. Animals were delivered by cesarean delivery at 160 days. A novel DCE-MRI protocol was utilized to calculate placental perfusion from maternal spiral arteries. Placental tissue was processed for histopathology. RESULTS: Placental volume blood flow was significantly reduced in nicotine-only animals compared with controls and nicotine plus vitamin C groups (P = .03). Maternal placental blood flow was not different between experimental groups by DCE-MRI, ranging from 0.75 to 1.94 mL/mL per minute (P = .93). Placental histology showed increased numbers of villous cytotrophoblast cell islands (P < .05) and increased syncytiotrophoblast sprouting (P < .001) in nicotine-only animals, which was mitigated by vitamin C. CONCLUSION: Prenatal nicotine exposure significantly decreased fetal blood supply via reduced placental volume blood flow, which corresponded with placental histological findings previously associated with cigarette smoking. Vitamin C supplementation mitigated the harmful effects of prenatal nicotine exposure on placental hemodynamics and development, suggesting that its use may limit some of the adverse effects associated with smoking during pregnancy.
OBJECTIVE: We previously demonstrated that prenatal nicotine exposure decreases neonatal pulmonary function in nonhuman primates, and maternal vitamin C supplementation attenuates these deleterious effects. However, the effect of nicotine on placental perfusion and development is not fully understood. This study utilizes noninvasive imaging techniques and histological analysis in a nonhuman primate model to test the hypothesis that prenatal nicotine exposure adversely effects placental hemodynamics and development but is ameliorated by vitamin C. STUDY DESIGN: Time-mated macaques (n = 27) were divided into 4 treatment groups: control (n = 5), nicotine only (n = 4), vitamin C only (n = 9), and nicotine plus vitamin C (n = 9). Nicotine animals received 2 mg/kg per day of nicotine bitartrate (approximately 0.7 mg/kg per day free nicotine levels in pregnant human smokers) from days 26 to 160 (term, 168 days). Vitamin C groups received ascorbic acid at 50, 100, or 250 mg/kg per day with or without nicotine. All underwent placental dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) at 135-140 days and Doppler ultrasound at 155 days to measure uterine artery and umbilical vein velocimetry and diameter to calculate uterine artery volume blood flow and placental volume blood flow. Animals were delivered by cesarean delivery at 160 days. A novel DCE-MRI protocol was utilized to calculate placental perfusion from maternal spiral arteries. Placental tissue was processed for histopathology. RESULTS: Placental volume blood flow was significantly reduced in nicotine-only animals compared with controls and nicotine plus vitamin C groups (P = .03). Maternal placental blood flow was not different between experimental groups by DCE-MRI, ranging from 0.75 to 1.94 mL/mL per minute (P = .93). Placental histology showed increased numbers of villous cytotrophoblast cell islands (P < .05) and increased syncytiotrophoblast sprouting (P < .001) in nicotine-only animals, which was mitigated by vitamin C. CONCLUSION: Prenatal nicotine exposure significantly decreased fetal blood supply via reduced placental volume blood flow, which corresponded with placental histological findings previously associated with cigarette smoking. Vitamin C supplementation mitigated the harmful effects of prenatal nicotine exposure on placental hemodynamics and development, suggesting that its use may limit some of the adverse effects associated with smoking during pregnancy.
Authors: G Acharya; V Sitras; T Erkinaro; K Mäkikallio; T Kavasmaa; M Päkkilä; J C Huhta; J Räsänen Journal: Ultrasound Obstet Gynecol Date: 2007-04 Impact factor: 7.299
Authors: Tina H Lassen; Mia Madsen; Lene T Skovgaard; Katrine Strandberg-Larsen; Jørn Olsen; Anne-Marie N Andersen Journal: Paediatr Perinat Epidemiol Date: 2010-05 Impact factor: 3.980
Authors: Jamie O Lo; Matthias C Schabel; Victoria H J Roberts; Xiaojie Wang; Katherine S Lewandowski; Kathleen A Grant; Antonio E Frias; Christopher D Kroenke Journal: Am J Obstet Gynecol Date: 2017-01-30 Impact factor: 8.661
Authors: Victoria H J Roberts; Jamie O Lo; Katherine S Lewandowski; Peter Blundell; Kevin L Grove; Christopher D Kroenke; Elinor L Sullivan; Charles T Roberts; Antonio E Frias Journal: Reprod Sci Date: 2017-04-26 Impact factor: 3.060
Authors: Victoria H J Roberts; Jamie O Lo; Jennifer A Salati; Katherine S Lewandowski; Jonathan R Lindner; Terry K Morgan; Antonio E Frias Journal: Am J Obstet Gynecol Date: 2016-03 Impact factor: 8.661
Authors: Jamie O Lo; Victoria H J Roberts; Matthias C Schabel; Xiaojie Wang; Terry K Morgan; Zheng Liu; Colin Studholme; Christopher D Kroenke; Antonio E Frias Journal: Reprod Sci Date: 2017-03-23 Impact factor: 3.060
Authors: Cindy T McEvoy; Kristin F Milner; Ashley J Scherman; Diane G Schilling; Christina J Tiller; Brittany Vuylsteke; Lyndsey E Shorey-Kendrick; Eliot R Spindel; Robert Schuff; Julie Mitchell; Dawn Peters; Jill Metz; David Haas; Keith Jackson; Robert S Tepper; Cynthia D Morris Journal: Contemp Clin Trials Date: 2017-05-08 Impact factor: 2.226
Authors: Leah Yieh; Cindy T McEvoy; Scott W Hoffman; Aaron B Caughey; Kelvin D MacDonald; Dmitry Dukhovny Journal: J Perinatol Date: 2018-05-22 Impact factor: 2.521